SerpinA3N deficiency attenuates steatosis and enhances insulin signaling in male mice
Journal of Endocrinology · 2023
DOI: 10.1530/joe-22-0073 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Endocrinology, 2023. Verfasst von Melanie Tran und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Neurobiology, University of Connecticut, Storrs, Connecticut, USA. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Diabetes Mellitus, Type 2, Insulin Resistance, Serpins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS.
Abstract (Originalsprache)
Aberrant hepatic lipid metabolism is the major cause of non-alcoholic fatty liver disease (NAFLD) and is associated with insulin resistance and type 2 diabetes. Serine (or cysteine) peptidase inhibitor, clade A, member 3N (SerpinA3N) is highly expressed in the liver; however, its functional role in regulating NAFLD and associated metabolic disorders are not known. Male wildtype and hepatocyte Serpina3N knockout (HKO) mice were fed a control diet, methionine- and choline-deficient diet or high-fat high-sucrose diet to induce NAFLD and markers of lipid metabolism and glucose homeostasis were assessed. SerpinA3N protein was markedly induced in mice with fatty livers. Hepatic deletion of SerpinA3N attenuated steatosis which correlated with altered lipid metabolism genes, increased fatty acid oxidation activity and enhanced insulin signaling in mice with NAFLD. Additionally, SerpinA3N HKO mice had reduced epididymal white adipose tissue mass, leptin, and insulin levels, improved glucose tolerance, and enhanced insulin sensitivity which was associated with elevated insulin-like growth factor binding protein-1 (IGFBP1) and activation of the leptin receptor (LEPR)-STAT3 signaling pathway. Our findings provide a novel insight into the functional role of SerpinA3N in regulating NAFLD and glucose homeostasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Neurobiology, University of Connecticut, Storrs, Connecticut, USA.
- Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, USA.
ORCID-Profile: Melanie Tran
Förderung
- NIAAA NIH HHS
Zitieren
APA
Tran, M., Mostofa, G., Picard, M., Wu, J., Wang, L., & Shin, D. J. (2023). SerpinA3N deficiency attenuates steatosis and enhances insulin signaling in male mice. Journal of Endocrinology. https://doi.org/10.1530/joe-22-0073
Vancouver
Tran M, Mostofa G, Picard M, Wu J, Wang L, Shin DJ. SerpinA3N deficiency attenuates steatosis and enhances insulin signaling in male mice. Journal of Endocrinology. 2023. doi:10.1530/joe-22-0073
BibTeX
@article{Tran2023,
author = {Tran, Melanie and Mostofa, Golam and Picard, Michael and Wu, Jianguo and Wang, Li and Shin, Dong-Ju},
title = {SerpinA3N deficiency attenuates steatosis and enhances insulin signaling in male mice},
journal = {Journal of Endocrinology},
year = {2023},
doi = {10.1530/joe-22-0073}
}
EUVIMED